Table I.
Distribution of selected characteristics of a SCCHN patient cohort (n = 1376)
| Variable | Total |
SPM free |
SPM |
P-valuesa | |||
| N | % | n | % | n | % | ||
| Total patients | 1376 | 100 | 1266 | 92.0 | 110 | 8.0 | |
| Age | 57.3 ± 11.3 | 57.0 ± 11.5 | 60.8 ± 7.9 | <0.010 | |||
| ≤ median (57 years) | 722 | 52.5 | 686 | 54.2 | 36 | 32.7 | <0.001 |
| > median (57 years) | 654 | 47.5 | 580 | 45.8 | 74 | 67.3 | |
| Sex | 0.734 | ||||||
| Male | 1045 | 75.9 | 960 | 75.8 | 85 | 77.3 | |
| Female | 331 | 24.1 | 306 | 24.2 | 25 | 22.7 | |
| Ethnicity | 0.090 | ||||||
| Non-Hispanic white | 1154 | 83.9 | 1068 | 84.4 | 86 | 78.2 | |
| Other | 222 | 16.1 | 198 | 15.6 | 24 | 21.8 | |
| Smoking | 0.022 | ||||||
| Never | 379 | 27.5 | 359 | 28.4 | 20 | 18.2 | |
| Ever | 997 | 72.5 | 907 | 71.6 | 90 | 81.8 | |
| Alcohol | 0.050 | ||||||
| Never | 369 | 26.8 | 349 | 27.6 | 21 | 19.1 | |
| Ever | 1007 | 73.2 | 917 | 72.4 | 89 | 80.9 | |
| Index cancer site | 0.118 | ||||||
| Oral cavity | 452 | 32.9 | 418 | 33.0 | 34 | 30.9 | |
| Oropharynx | 618 | 44.9 | 575 | 45.4 | 43 | 39.1 | |
| Larynx/hypopharynx | 306 | 22.2 | 273 | 21.6 | 33 | 30.0 | |
| Index cancer stage | 0.830 | ||||||
| 1 or 2 | 351 | 25.5 | 322 | 25.4 | 29 | 26.4 | |
| 3 or 4 | 1025 | 74.5 | 944 | 74.6 | 81 | 73.6 | |
| Treatment | 0.982 | ||||||
| Surgery | 247 | 17.9 | 228 | 18.0 | 19 | 17.3 | |
| Surgery + adjuvant Txb | 341 | 24.8 | 312 | 24.6 | 29 | 26.4 | |
| XRTc | 346 | 25.2 | 319 | 25.2 | 27 | 24.5 | |
| XRT + chemotherapy | 442 | 32.1 | 407 | 32.2 | 35 | 31.8 | |
P-values were calculated from the chi-square test.
Adjuvant Tx: adjuvant radiotherapy and/or chemotherapy.
XRT: radiotherapy.